Rui Meng

长春师范大学

H指数:15

被引数:731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Affinity-guided and activity-oriented consecutive-CCC/UNIFAC of acetylcholinesterase-binding ginsenosides from Black ginseng: Extraction optimization and activity characterization

亲和引导和活性导向的连续CCC/UNIFAC法从黑参中分离乙酰胆碱酯酶结合型人参皂苷：提取优化和活性表征

Journal of Chromatography A

IF4

2026-09-170

PRE

Development and validation of a small extracellular vesicle-derived RNA signature for early diagnosis of lung adenocarcinoma and prognosis in advanced stages

用于晚期肺腺癌早期诊断和预后的小胞外囊泡衍生RNA标签的开发和验证

Molecular Cancer

IF33.9

2025-12-030

OAAI

The interfacial polymerization reaction induced by intermolecular dipole-dipole interaction for the preparation of nanofiltration membrane under the low concentration of the aqueous monomers

低浓度水溶液中分子间偶极-偶极相互作用引发的界面聚合反应制备纳滤膜

SEPARATION AND PURIFICATION TECHNOLOGY

IF9

2025-07-011

PRE

A new method for the mitigation of piperazine transfer rate to prepared nanofiltration membranes by modified PVDF substrate through MOF-303@GO

SEPARATION AND PURIFICATION TECHNOLOGY

IF9

2025-07-010

PRE

CTAB optimized TiO2@Fe3S4 photocatalyst for efficient separation and homogeneous degradation of organic pollutants

CTAB优化的TiO2@Fe3S4光催化剂用于有机污染物的高效分离和均相降解

JOURNAL OF ALLOYS AND COMPOUNDS

IF6.3

2025-06-010

PRE

Zn-TiO2/AC photocatalysts for pollutants degradation from experimental and DFT studies

Zn-TiO2/AC光催化剂对污染物降解的实验与DFT研究

MOLECULAR CATALYSIS

IF4.9

2025-05-010

PRE

Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18-40 years in China

中国18-40岁青年人群中家族性高胆固醇血症普遍基因筛查的成本效益

BMC MEDICINE

IF8.3

2025-03-050

Analysis of Toxic Elements Pollution Sources and Crop Health Risks in Soil of Typical Thallium Mining Area

ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY

IF2.2

2025-01-030

Single-cell and multi-omics analyses highlight cancer-associated fibroblasts-induced immune evasion and epithelial mesenchymal transition for smoking bladder cancer

TOXICOLOGY

IF4.6

2024-05-011

PRE

A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia

家族性高胆固醇血症不同筛查策略的成本-效果分析的系统评价

JOURNAL OF CLINICAL LIPIDOLOGY

IF4.6

2024-01-013

PRE

scAAGA: Single cell data analysis framework using asymmetric autoencoder with gene attention

scAAGA: 使用具有基因注意力的不对称自动编码器的单细胞数据分析框架

COMPUTERS IN BIOLOGY AND MEDICINE

IF6.3

2023-10-0167

PRE

EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study

Egfr-tkis联合立体定向放疗 (SBRT) 治疗IV期非小细胞肺癌 (NSCLC): 一项前瞻性，多中心，随机，对照的II期研究

RADIOTHERAPY AND ONCOLOGY

IF5.3

2023-07-0120

OAAI

The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: A Bayesian network meta-analysis

FRONTIERS IN MEDICINE

IF3

2022-09-169

OAAI

RETRACTION: MicroRNA-744 inhibits tumor cell proliferation and invasion of gastric cancer via targeting brain-derived neurotrophic factor (Retraction of Vol 16, Pg 5055, 2017)

MOLECULAR MEDICINE REPORTS

IF3.5

2022-07-270

OAAI

The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-03-3112

OAAI

Evaluation of Environmental and Economic Integrated Benefits of Photovoltaic Poverty Alleviation Technology in the Sanjiangyuan Region of Qinghai Province

SUSTAINABILITY

IF3.3

2021-11-2910

Will the Inducing and Maintaining Remission of Non-biological Agents and Biological Agents Differ for Crohn's Disease? The Evidence From the Network Meta-Analysis

非生物制剂和生物制剂对克罗恩病的诱导和维持缓解是否会有所不同？来自网络荟萃分析的证据

FRONTIERS IN MEDICINE

IF3

2021-09-014

OAAI

Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naive Patients With Moderate-to-Severe Ulcerative Colitis in China

FRONTIERS IN PUBLIC HEALTH

IF3.4

2021-08-209

OAAI

A comparison of self-reported and proxy-reported health utilities in children: a systematic review and meta-analysis

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2021-02-0521

OAAI

Economic Evaluation of Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine for the Treatment of First-Line Advanced Metastatic Triple-Negative Breast Cancer in China: Using Markov Model and Partitioned Survival Model

ADVANCES IN THERAPY

IF4

2020-07-0918

PREAI

Rui Meng

个人简介

教育背景

工作经历

荣誉奖项

研究方向